Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review (Q34073347)

30 July 2017

4 references

22 June 2019

19 September 2019

27 August 2020

3 December 2020

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review (English)

1 reference

biomedical investigative technique

30 July 2017

1 reference

19 September 2019

1 reference

27 August 2020

1 reference

3 December 2020

1 reference

5

0 references

Gloria Córdoba

object named as

Gloria Cordoba

series ordinal

1

0 references

Steven Woloshin

series ordinal

3

object named as

Steven Woloshin

1 reference

30 July 2017

2

Lisa Schwartz

1 reference

30 July 2017

Harold Bae

4

1 reference

PubMed ID

20719825

30 July 2017

language of work or name

English

0 references

publication date

18 August 2010

5 references

30 July 2017

22 June 2019

19 September 2019

27 August 2020

3 December 2020

5 references

30 July 2017

22 June 2019

19 September 2019

27 August 2020

3 December 2020

341

1 reference

30 July 2017

c3920

1 reference

Creative Commons Attribution-NonCommercial

30 July 2017

4 references

22 June 2019

19 September 2019

27 August 2020

3 December 2020

Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Composite outcomes in cardiovascular research: a survey of randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Composite outcomes in randomized clinical trials: arguments for and against

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Believability of relative risks and odds ratios in abstracts: cross sectional study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Validity of composite end points in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Composite end points in randomized trials: there is no free lunch

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

Combined endpoints: can we use them?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923692

The FDA's critique of the anturane reinfarction trial

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20719825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20719825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sulfinpyrazone in the prevention of sudden death after myocardial infarction

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20719825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.C3920

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

20719825